login
login
Image header Agence Europe
Europe Daily Bulletin No. 11126
Contents Publication in full By article 30 / 35
ECONOMY - FINANCE - BUSINESS / (ae) competition

Allergopharma-Stallergenes-Leti joint venture

Brussels, 22/07/2014 (Agence Europe) - On Tuesday 22 July, the European Commission gave the go-ahead to the creation of a joint venture by Allergopharma GmbH & Co. KG of Germany, Stallergenes S.A. of France and Laboratorios LETI, S.L. Unipersonal of Spain. Allergopharma is active in the fields of allergen immunotherapy, allergy diagnostics and allergy prevention in 25 countries, but mostly in Germany; Stallergenes is a global healthcare company specialised in the diagnosis and treatment of...

Contents

EXTERNAL ACTION
INSTITUTIONAL
SECTORAL POLICIES
ECONOMY - FINANCE - BUSINESS
COURT OF JUSTICE OF THE EU
WEEKLY SUPPLEMENT